Evolution of the Average Target: Colgate-Palmolive Company

Evolution of the Average Target - Colgate-Palmolive Company

Evolution of the Target Price: Colgate-Palmolive Company

Evolution of the Target Price - Colgate-Palmolive Company

Changes in Analyst Recommendations: Colgate-Palmolive Company

d22391.pQdxN7tJoB8tBLCwwlIzmEfPSv6uMGzc_euRGzR4mCI.xkkaX9UKySoZYMfHpSAGzROHIc72ZiTllJmkf1tI2Wv_fTZ61y7_cGE14Q~9570b72f759eb3f4795bce2b42d6f864
10-28 Colgate-Palmolive's Q3 Results Unlikely to Materially Shift North America Narrative, RBC Says MT
10-21 Colgate-Palmolive Expected to Post In-Line Q3 Results, UBS Says MT
10-19 JPMorgan Adjusts Price Target on Colgate-Palmolive to $104 From $103 MT
10-15 UBS Adjusts Colgate-Palmolive Price Target to $106 From $109, Maintains Buy Rating MT
10-09 Consumer Staple Companies Eye Stabilizing Consumption Ahead of Earnings, BofA Says MT
10-09 BofA Adjusts Price Target on Colgate-Palmolive to $100 From $102, Keeps Buy Rating MT
10-08 Evercore ISI Adjusts Price Target on Colgate-Palmolive to $101 From $100 MT
10-05 Wells Fargo Adjusts Price Target on Colgate-Palmolive to $90 From $95, Maintains Equalweight Rating MT
09-28 BNP Paribas Adjusts PT on Colgate-Palmolive to $97 From $101, Keeps Outperform Rating MT
09-21 Piper Sandler Adjusts PT on Colgate-Palmolive to $95 From $98, Maintains Overweight Rating MT
09-21 Analyst recommendations: Flutter, Constellation Brands, CoreWeave, eBay, Meta Platforms… Zonebourse
09-08 Colgate-Palmolive Could Stabilize US Business in 2027, RBC Says MT
08-03 Colgate-Palmolive Organic Sales Growth to Return to 3%-4% in H2 2026 and 2027, Morgan Stanley Says MT
08-03 UBS Adjusts Price Target on Colgate-Palmolive to $109 From $106, Maintains Buy Rating MT
08-03 RBC Capital Adjusts Colgate-Palmolive PT to $104 From $102, Maintains Outperform Rating MT
08-03 Analyst recommendations: Chevron, Linde, RTX, Colgate-Palmolive, American Electric Power... Zonebourse
08-03 Deutsche Bank Adjusts Colgate-Palmolive Price Target to $101 From $99, Maintains Buy Rating MT
08-03 Evercore ISI Adjusts Price Target on Colgate-Palmolive to $101 From $100, Maintain Outperform Rating MT
08-03 BNP Paribas Adjusts Price Target on Colgate-Palmolive to $101 From $97, Maintain Outperform Rating MT
08-03 Raymond James Adjusts PT on Colgate-Palmolive to $102 From $100, Maintain Outperform Rating MT
08-03 TD Cowen Adjusts Price Target on Colgate-Palmolive to $90 From $85, Maintain Hold Rating MT
08-03 Jefferies Adjusts Price Target on Colgate-Palmolive to $89 From $88, Maintain Hold Rating MT
08-03 Morgan Stanley Adjusts PT on Colgate-Palmolive to $104 From $100, Maintain Overweight Rating MT
07-29 Colgate-Palmolive Seen Supported by Emerging Markets Growth, RBC Capital Markets Says MT
07-23 Colgate-Palmolive's Q2 Organic Sales Growth to Be Driven by Continued International Momentum, UBS Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.49%
+8.84%
+0.38%
+5.2%
+9.44%
+1.57%
+0.36%
+4.66%
+10.62%
Average +5.28%
Weighted average by Cap. +5.40%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
91.69USD
Average target price
98.15USD
Spread / Average Target
+7.05%
High Price Target
110.00USD
Spread / Highest target
+19.97%
Low Price Target
87.00USD
Spread / Lowest Target
-5.12%

Analyst Consensus Detail

Analyst consensus - Colgate-Palmolive Company

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Colgate-Palmolive Company
Trader
Investor
Global
Quality
ESG MSCI
AAA
MarketScreener Ratings - Colgate-Palmolive Company
  1. Stock Market
  2. Stocks
  3. CL Stock
  4. Consensus Colgate-Palmolive Company